Indivior Pharmaceuticals, Inc., together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, E...
Q2 2026
Aug 6, 2026
Q1 2026
Apr 30, 2026
FY 2025
Feb 26, 2026
Q4 2025
Q3 2025
Oct 30, 2025